# Inotropes and vasopressors

Drug · id `cardio:inotropes-and-vasopressors` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Inotropic agents; Positive inotropes; Cardiotonic agents; Vasopressor agents; Vasoconstrictor agents

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Heart failure; Acute care and long-term living  

## In plain language

Inotropes are medicines that strengthen the heart, and vasopressors are medicines that narrow blood vessels. MeSH describes cardiotonic agents as agents that strengthen the heart or increase cardiac output, and vasoconstrictor agents as drugs that constrict blood vessels. US labels call dobutamine an inotropic agent, milrinone a positive inotrope and vasodilator, and norepinephrine a peripheral vasoconstrictor and an inotropic stimulator of the heart. This is the class page.

## Technical summary

Class page. Two MeSH descriptors, both broad matches because each covers only half of the page: D002316 (Cardiotonic Agents, strengthening effect on the heart or increased cardiac output, named uses after myocardial infarction and cardiac surgery, in shock and in heart failure) and D014662 (Vasoconstrictor Agents, drugs used to cause constriction of the blood vessels). Vasopressor Agents is a MeSH entry term of the second (read 2026-11-18, hash only). The three members are filed by label wording, not by RxClass: the labels read (Hikma milrinone lactate, ANDA077966; Baxter dobutamine in dextrose, NDA020255; Hospira Levophed, NDA007513) call the products a positive inotrope, an inotropic agent and an inotropic stimulator of the heart, and RxClass gives them three different pharmacologic classes (Phosphodiesterase 3 Inhibitor, beta-Adrenergic Agonist and Catecholamine), none of which is named for the inotrope effect. The milrinone label says milrinone differs in structure and mode of action from the digitalis group and from the catecholamines, so the class groups by effect, not by chemistry. The Levophed label lists raising blood pressure in adults with severe, acute hypotension. Statements are scoped to the labels read. No trial result and no dose is recorded.

## Connected pages

- Files under this front: Medicines (`cardio:front-medicines`)
- MeSH names heart failure among the uses of cardiotonic agents: Heart failure (`cardio:heart-failure`)
- MeSH names shock among the uses of cardiotonic agents; cardiogenic shock is one kind of shock: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Related to: Cardiac glycosides (digoxin) (`cardio:cardiac-glycosides-digoxin`)
- Has subtype: Dobutamine (`cardio:dobutamine`)
- Has subtype: Milrinone (`cardio:milrinone`)
- Has subtype: Norepinephrine (`cardio:norepinephrine`)

## Provenance

Content hash: 993998e64694dfbd469046da6c7a7fcc3e09bf4b4f3735087c4bafb9146d1493
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
